Brukinsa (zanubrutinib)

pCPA File Number: 21965
Negotiation Status:
Negotiations were not pursued
Indication(s):
For the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.
Sponsor/Manufacturer:
BeiGene, Ltd.
CADTH Project Number:
PC0267
pCPA Engagement Letter Issued:
Negotiation Process Concluded: